Page 2 - Process Research News Today

Starting in 2023, Celyad Oncology is now entirely focused on its new business strategy with one clear objective: help to overcome the current limitations of CAR-T approaches. It plans to do this via

Celyad Oncology (CYAD) said it will recognize a non-cash impairment of its goodwill and intangible oncology assets and that its board plans to submit for a vote its business plan...

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and fiscal year ended December 31,...

Accelerating parts of the drug discovery process by combining automation and analytical technologies is essential for the pharmaceutical industry. Read more here.

The National Research and Innovation Agency (BRIN) has created nutritious biscuits for pregnant women to ensure they get adequate nutrition in order to ...

The National Research and Innovation Agency (BRIN) has developed a soybean hydrolyzate production technology to increase the iron content in food to ...

A new paper from Asynt, written by a multidisciplinary team of experts at the Institute for Process Research and Chemistry (iRPD) at the University of Leeds, describes how the fReactor flow chemistry system with add-on photochemical flow modules improves synthetic reactions commonly used in the preparation of drug intermediates. Click to read more...

Canada announced key projects while at the Commonwealth Heads of Government Meeting, including Process Research Ortech's (PRO) mining project in Botswana with investment partners – valued at CAD $129 million (USD $100 million), as announced

SAN DIEGO, Feb. 11, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter ...

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and fiscal year ended December 31,...